LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...

The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...

Finland: Researchers have discovered in new research that young children with acute wheezing showed greater clinically ...

BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a leader in inhaled respiratory therapeutics, today announced the results of a groundbreaking study examining the aerosol composition of various ...

Molex LLC, parent to medical supplier Phillips-Medisize LLC, has signed an agreement through its Molex Asia Holdings Ltd. affiliate to acquire Vectura Group Ltd. from Vectura Fertin Pharma Inc., a ...

The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure ...

Researchers from the University of Colorado-Boulder just discovered a quick and easy way to regulate blood pressure — a problem that afflicts about 108 million or 45% of people in the U.S. and can ...

Greenlane and CURB have also agreed to explore the development and distribution of a comprehensive portfolio of lifestyle products designed to seamlessly fit into the daily lives of consumers.

Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better understand ...